Autoantibodies and damage in patients with idiopathic inflammatory myopathies: alongitudinal multicenter study from the MYONET international network (2024)
- Authors:
- Autor USP: SHINJO, SAMUEL KATSUYUKI - FM
- Unidade: FM
- DOI: 10.1016/j.semarthrit.2024.152529
- Subjects: AUTOANTICORPOS; ESTUDOS LONGITUDINAIS; MIOPATIAS CONGÊNITAS ESTRUTURAIS
- Agências de fomento:
- National Institution for Health Research (NIHR) Manchester Biomedical Research Centre
- Boehringer Ingelheim
- Czech Ministry of Health Conceptual Development of Research Organization
- Swedish Research Council
- King Gustaf V 80 Year Foundation
- Region Stockholm (ALF project)
- Heart and Lung Foundation
- Swedish Rheumatism Association
- Konung Gustaf V:s, Drottning Victorias Frimurarestiftelse
- Swedish Research Council [2020-01378] Funding Source: Swedish Research Council
- Swedish Heart-Lung Foundation [20200379] Funding Source: Swedish Heart-Lung Foundation
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2024
- Source:
- Título: Seminars in Arthritis and Rheumatism
- ISSN: 0049-0172
- Volume/Número/Paginação/Ano: v. 68, article ID 152529, 10p, 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ESPINOSA-ORTEGA, Fabricio et al. Autoantibodies and damage in patients with idiopathic inflammatory myopathies: alongitudinal multicenter study from the MYONET international network. Seminars in Arthritis and Rheumatism, v. 68, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/79475. Acesso em: 25 jan. 2026. -
APA
Espinosa-ortega, F., Lodin, K., Dastmalchi, M., Vencovsky, J., Diederichsen, L. P., Shinjo, S. K., et al. (2024). Autoantibodies and damage in patients with idiopathic inflammatory myopathies: alongitudinal multicenter study from the MYONET international network. Seminars in Arthritis and Rheumatism, 68. doi:10.1016/j.semarthrit.2024.152529 -
NLM
Espinosa-ortega F, Lodin K, Dastmalchi M, Vencovsky J, Diederichsen LP, Shinjo SK, Danieli MG, Selva-o'Callaghan A, Visser M de, Griger Z. Autoantibodies and damage in patients with idiopathic inflammatory myopathies: alongitudinal multicenter study from the MYONET international network [Internet]. Seminars in Arthritis and Rheumatism. 2024 ; 68[citado 2026 jan. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/79475 -
Vancouver
Espinosa-ortega F, Lodin K, Dastmalchi M, Vencovsky J, Diederichsen LP, Shinjo SK, Danieli MG, Selva-o'Callaghan A, Visser M de, Griger Z. Autoantibodies and damage in patients with idiopathic inflammatory myopathies: alongitudinal multicenter study from the MYONET international network [Internet]. Seminars in Arthritis and Rheumatism. 2024 ; 68[citado 2026 jan. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/79475 - Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies
- COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies
- Dor em reumatologia
- Insulin resistance is increased in adult patients with dermatomyositis
- Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study
- A prospective cross-sectional study of serum IL-17A in antisynthetase syndrome
- Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis
- The aerobic capacity in patients with antisynthetase syndrome and dermatomyositis
- Breaking the diagnosis. [Editorial]: ankylosing spondylitis evidenced by cervical fracture following spine manipulation
- Dor em reumatologia
Informações sobre o DOI: 10.1016/j.semarthrit.2024.152529 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
